UN health R&D summit 'leaves the greater part of the job undone.' MSF's Statement at the close of the UN Health R&D Summit
Food Crisis Campaign director talks to the BBC about the food crisis and highlights children's special nutritional needs

‘Concrete proposals to ensure urgently needed drugs and diagnostics are developed for developing country diseases have not received support. Considering the colossal needs we see in MSF daily practice, this is a lost opportunity,’ said Dr. Tido von Schoen-Angerer, Director of Médecins Sans Frontières (MSF)’s Access Campaign at the close of UN health R&D summit.
Read the MSF press release (Monday 28th April)
Read more about the IGWG and what it can do
Latest Updates from the MSF team at the IGWGThursday 1 May Read MSF's statement to the IGWG Read Monday's update as the negotiations kick off Read MSF's earlier submissions to the IGWG Read MSF's report on progress at the IGWG Read MSF's Comments to the European Commission on the WHO draft Global Strategy and Plan of Action on public health, innovation and IP
|
Put Patients First
Under discussion at the IGWG negotiations are a variety of proposals to stimulate both better access to existing drugs and steer research and development agendas towards the greatest medical needs. Click here to read more about them |
Is the GAVI plan for pneumococcal vaccine too expensive ?
The pneumococcal vaccine could save millions of lives. But the Advance Market Commitment, set up by GAVI to fund it, is far too expensive. Read the Campaign's director, Dr. Tido von Schoen-Angerer, in Development Today. |
Introduction to Medical Innovation |
The Hospital on the Edge of Town: Treating MDR TB in Karakalpakstan